forum

AUROPHARMA Share Price Discussion

Aurobindo Pharma Ltd.
Sector: Pharmaceuticals and health care
... Read more
AUROPHARMA Share Price *
589.55 +0.05 (0.01%)
* (quote may be delayed)
  • AUROPHARMA - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization46,051.74
    Enterprise Value50,495.97
    Price to Earnings18.01
    Price to Book Value4.06
    Return on Capital Employed0.17
    Return on Equity0.18
    Face Value1
    Dividend Yield0.01
  • AUROPHARMA Share Price - Technicals

    keyboard_arrow_down
    AUROPHARMA - 52 Week High₹838
    AUROPHARMA - 52 Week Low₹536.6

AUROPHARMA Discussion Forum

HIDDEN GEM in AUROPHARMA
AUROPHARMA VERY STRONG SUPPORT NEAR 592 IF BREAK THEN 585-572-560 LEVELS SEEN ONLY BUY ABOVE 602 ...

AUROPHARMA 584 LOW FROM 592......8,000 NON STOP PROFIT
Like
reply
Reply (2)
share
Share
Latest replies

585 sell hai

Hold or exit

AUROPHARMA VERY STRONG SUPPORT NEAR 592 IF BREAK THEN 585-572-560 LEVELS SEEN
ONLY BUY ABOVE 602 FOR TGTS 609-616-623
Like
reply
Reply
share
Share

"RISKY JACKPOT"
AUROPHARMA SELL BELOW 597.50
SL 599
TARGET "OPEN"
Like
reply
Reply (1)
share
Share
Latest replies

NEW LOW 594
(-1500/- RISK PER LOT)😍
RISK 1: 2.30 TIMES PROFIT❤️
3,500/- PROFIT TILL NOW👍
Hustle With Ichimoku in AUROPHARMA
Bearish trade at 604

Auro Pharma 604 to 598 bearish trade
AUROPHARMA - chart - 314228
Like
reply
Reply
share
Share

Bearish trade at 604
AUROPHARMA - chart - 313985
Like
reply
Reply
share
Share

Buy auropharma 560 pe CMP 7.5 sl 5 target 9,12
Like
reply
Reply (1)
share
Share
Latest replies

9 first done🔥🔥🔥
Hold Aurobindo Pharma; target of Rs 710: Sharekhan
Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 710 in its research report dated August 08, 2019.
moneycontrol.com
Like
reply
Reply
share
Share
Check out the week’s top 10 movers and shakers
The Sensex gained 463.69 points to end at 37,581.91, while Nifty ended at 11,109.7, up 112.35 points last week.
moneycontrol.com
Like
reply
Reply
share
Share
Surprise or disappointment in Q1: Here’s how top companies have performed this week
Experts say that there is a possibility double-digit earnings growth could be seen after the September quarter
moneycontrol.com
Like
reply
Reply
share
Share

BUY AUROPHARMA FUTURE @512 SL 3 TARGET 518
Like
reply
Reply (2)
share
Share
Latest replies

NEW HIGH 515,95

RS 3950 PROFIT TILL NOW

Auropharam 700 Call cmp 1.15 Sl 0 tgt Rajnikant Hold till expiry
Like
reply
Reply
share
Share

Level for AUROPHARMA
Buy abv 610 for 612 614 616
Sell blw 598 for 596 594 592
Sl 4 point for both
Like
reply
Reply (2)
share
Share
Latest replies

Low 596.6
1400 running profit
Small Traders can book profit

Level 1 all trgt achieved 👍👍👍
High made 615.95
5950 profit booked
Small Traders can book profit
Buy Aurobindo Pharma; target of Rs 735: ICICI Direct
ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 735 in its research report dated August 08, 2019.
moneycontrol.com
Like
reply
Reply
share
Share
Aurobindo Pharm Standalone June 2019 Net Sales at Rs 3,078.83 crore, up 20.32% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share
Aurobindo Pharm Consolidated June 2019 Net Sales at Rs 5,444.60 crore, up 28.1% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share

SELL AUROPHARMA @593 SL 2 POINT TARGET 588-582
Like
reply
Reply (1)
share
Share
Latest replies
Aurobindo Pharma climbs 8% after Q1 earnings beat analyst expectations
The antiretroviral drug sales doubled to Rs 318.5 crore over the year-ago period.
moneycontrol.com
Like
reply
Reply
share
Share

AUROPHARMA
550 TO 597 + 47000
almost DOT TGT 1
CHAPO INDIA CHAPO
Like
reply
Reply
share
Share

START WATCHING - AUROPHARMA IS RUNNING NON STOP TODAY
Like
reply
Reply (1)
share
Share
Latest replies
Neeraj Puri G @neeraj
Aug 8 8:51 PM

As suggested AUROPHARMA also blasted today
Bhavik Vora in AUROPHARMA
Buy Auropharma Fut at 582

592... 10k profit running.. book and close....
Like
reply
Reply
share
Share
Bhavik Vora in AUROPHARMA
Buy Auropharma Fut at 582

590.. 8k profit running
Like
reply
Reply
share
Share
Bhavik Vora in AUROPHARMA
Buy Auropharma Fut at 582

588... 6k profit running
Like
reply
Reply
share
Share
Bhavik Vora in AUROPHARMA
Buy Auropharma Fut at 582

586... 4k profit running
Like
reply
Reply
share
Share

Buy Auropharma Fut at 582
Like
reply
Reply
share
Share
Dhruv in AUROPHARMA
Auropharma can be bought for long term here. Its consolidating for a long time, and its availabl...

AuroPharma results beat estimates. Should fly today.
Like
reply
Reply
share
Share
Stocks in the news: Tata Steel, Maruti Suzuki, HCL Tech, Aurobindo, HPCL, Bosch, Siemens
Maruti Suzuki | HCL Technologies | Aurobindo Pharma | HPCL | Lemon Tree Hotels and Siemens are stocks which are in the news today.
moneycontrol.com
Like
reply
Reply
share
Share

AUROPHARMA - 304120
💠💠Drug firm Aurobindo Pharma on Wednesday reported a 39.52% rise in consolidated net profit to ₹635.68 crore for the quarter ended June 2019, mainly on account of robust sales in the US and Europe.
The company had posted a net profit of ₹455.59 crore for the corresponding peri...
Read more...
Like
reply
Reply
share
Share
Aurobindo Pharma Q1 net rises 40% to Rs 635.8 crore, beats street estimates
Revenues rose 28.1 percent YoY to Rs. 5,444.6 crore.
moneycontrol.com
Like
reply
Reply
share
Share

AUROPHARMA - chart - 303471
Auropharma can be bought for long term here. Its consolidating for a long time, and its available at the lower end of the channel.
Like
reply
Reply
share
Share

auropharam 620 call cmp 2.85 Result After market Risky one try future cmp 554.70 sl 537
1
reply
Reply (1)
share
Share
Latest replies
Pyramidstock @pyramidstock
Aug 8 2:49 PM

from 554 to 582 enjoy and book profit 620 call 2.85 to 6.25 3x return enjoy and book
ICEBERG TRADING in AUROPHARMA
Buy Aurobindo pharma CMP 563.65 sl 556 target 576 if hold here then 582 , 586 , 600 positional

Positional Directions within range 576 - 530 either side break will lead to 660 n down side 465 it's positional 3-4 weekly timeframe keep watching
Like
reply
Reply (4)
share
Share
Latest replies
Dhruv @DhruvMan
Aug 7 7:08 PM

Going to 465 looks very less likely. Breaking out looks more likely
Dhruv @DhruvMan
Aug 8 4:37 PM

Told you it will break out. Hope you made some money like I did :)

yes i made it stick with my trade setup which yesterday i post

will trail sl for up side target

Buy Aurobindo pharma CMP 563.65 sl 556 target 576 if hold here then 582 , 586 , 600 positional
Like
reply
Reply
share
Share

SELL AUROPHARMA FUTURE @560 SL 3 POINT TARGET 550-540
Like
reply
Reply (1)
share
Share
Latest replies
Stocks in the news: RIL, Indiabulls Housing, IRB Infra, Avenue Supermarts, Jet Airways, Tata Steel
IRB Infrastructure | Avenue Supermarts | Jet Airways | Tata Steel | Sheela Foam | NLC India and Essel Propack are stocks which are in the news today.
moneycontrol.com
Like
reply
Reply
share
Share

SELL AUROPHARMA FUTURE@557 SL 3 POINT TARGET 549-540
Like
reply
Reply (3)
share
Share
Latest replies

NEW LOW 555.60

NEW LOW 554.20

2.80*1000 =RS 2800 PROFIT
JACKPOT FNO Call in AUROPHARMA
SELL AUROPHARMA FUTURE @551 SL 2 POINT TARGET 545-538

THAT'S CALL PERFECT TARGET
Like
reply
Reply
share
Share

05-08-19 Intraday SELL AUROPHARMA in cash
only below @ 541
Like
reply
Reply (2)
share
Share
Latest replies
Sameer  @tradingfab
Aug 5 3:11 PM

AUROPHARMA -- LOW 539.70****
Sameer  @tradingfab
Aug 5 3:17 PM

AUROPHARMA --- LOW 536.60 ****

SELL AUROPHARMA FUTURE @551 SL 2 POINT TARGET 545-538
Like
reply
Reply (5)
share
Share
Latest replies

NEW LOW 543.15

NEW LOW 541.25

NEW LOW 538.15

BOTH TARGET DONE

RS 12850 PROFIT TILL

SELL AUROPHARMA FUTURE 552 SL 4 TARGET 543
Like
reply
Reply (8)
share
Share
Latest replies

NEW LOW 547.15

NEW LOW 546.55

RS 5450 PROFIT TILL NOW

NEW LOW 545.15

GIVE RS 7000 PROFIT TILL
Ggg in AUROPHARMA
1 call : Sell Auropharma fut @ 554-55, tgt below 542😂

Auropharma 555 to belw 545, 10k in pockets stay hapie
Like
reply
Reply
share
Share
Ggg in AUROPHARMA
Fresh sell Auropharma below 550 then ram ram only👈😂

Or ye Auropharma 550 ke aur badte hue rang jamane ki tyari mai lag rahe hai👈😂😝😢😢😢
Like
reply
Reply
share
Share
Ggg in AUROPHARMA
Hold now here cums the pain for Auropharma to crack below 540 today😥😂😢

Fresh sell Auropharma below 550 then ram ram only👈😂
Like
reply
Reply
share
Share
Ggg in AUROPHARMA
1 call : Sell Auropharma fut @ 554-55, tgt below 542😂

Hold now here cums the pain for Auropharma to crack below 540 today😥😂😢
Like
reply
Reply
share
Share

1 call : Sell Auropharma fut @ 554-55, tgt below 542😂
Like
reply
Reply
share
Share
Aurobindo’s Sandoz deal may face further delays
In September, Hyderabad-based Aurobindo announced that it would acquire the commercial operations of Swiss drug maker Novartis AGs’ generics unit in the US for $900 million. However, the proposed deal, which could emerge as the largest outbound deal by an Indian company, is yet to see the light of d…
moneycontrol.com
Like
reply
Reply
share
Share
ONE CALL in AUROPHARMA
@ONE_CALL💎 FUTURE CALL 🔥🔥 SELL AUROPHRMA 550-51 SL 558 TARGET 533++++

544🔥🔥🔥🔥💪 (PROFIT 14000 RS / 2 LOT )
Like
reply
Reply
share
Share

@ONE_CALL💎
FUTURE CALL 🔥🔥
SELL AUROPHRMA 550-51 SL 558 TARGET 533++++
Like
reply
Reply
share
Share

AUROPHARMA NSE CASH BUY ABOVE 575, FOR TARGET 580 - 585
CMP 570
Like
reply
Reply
share
Share

BUY AUROPHARMA CMP 572
Like
reply
Reply (1)
share
Share
Latest replies
Ashish Singh @ashishtrader
Jul 30 3:44 PM

SL REVISE TO COST AND HOLD

AUROPHARMA - chart - 284516
(TMT) AURO PHARMA (CMP 556):- AS PER HARMONIC FORMING MAX BUTTERFLY PATTERN ENTER BETWEEN 555-550 ZONE S/L 542 BELOW TGT 580-600+
1
reply
Reply (1)
share
Share
Latest replies
TMT VIEW @tmtview
Jul 26 5:49 PM

AURO PHARMA NOW 570
  • AUROPHARMA - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    9-Aug-19Prabhudas LilladherBuy715
    8-Aug-19Nirmal BangBuy868
    8-Aug-19ICICIdirect.comBuy735
    8-Aug-19SharekhanHold710
    28-Jun-19SharekhanHold710
    View all AUROPHARMA - Share Targets - Broker Reports
  • AUROPHARMA Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Aug 21599.1601.3587.4589.5
    Aug 20606.75606.75592.95600.25
    Aug 19605612.55598.25603.8
    Aug 16605611.9595.15602.3
    Aug 14605609581605.5
  • AUROPHARMA Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹573.35
    30 Day Moving Average₹576.37
    50 Day Moving Average₹591.31
    100 Day Moving Average₹665.22
    200 Day Moving Average₹712.7
  • AUROPHARMA - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue10,2709,607.050.07
    Operating Profit2,6702,373.950.12
    Profit Before Tax2,3432,178.570.08
    Net Income1,8131,706.760.06
  • AUROPHARMA - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds11,3519,9830.14
    Total Liabilities6,7906,1970.1
    Total Assets18,14116,1800.12
  • AUROPHARMA - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity9142,457.2-0.63
    Cash from Investing Activity-981-1,542.05-0.36
    Cash from Financing Activity440-1,328.99-1.33
    Net Cash Flow372-413.84-1.9
  • AUROPHARMA - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.110.13
    Return on Equity0.180.2
    Return on Capital Employed0.170.19
  • AUROPHARMA - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.27
    3 Year CAGR Growth in Operating Profit0.19
    3 Year CAGR Growth in EBIDTA0.19
    3 Year CAGR Growth in Net Income0.2
    3 Yr CAGR Growth - Diluted EPS-0.4
  • AUROPHARMA - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.89
    5 Year CAGR Growth in Operating Profit1.79
    5 Year CAGR Growth in EBIDTA1.79
    5 Year CAGR Growth in Net Income2.66
    3 Yr CAGR Growth - Diluted EPS0.82
  • AUROPHARMA Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 12 10:48 PM
    Hold Aurobindo Pharma; target of Rs 710: Sharekhan
    moneycontrol.com
    NewsBot
    Aug 10 5:23 PM
    Check out the week’s top 10 movers and shakers
    moneycontrol.com
    NewsBot
    Aug 10 2:58 PM
    Surprise or disappointment in Q1: Here’s how top companies have performed this week
    moneycontrol.com
    NewsBot
    Aug 8 10:33 PM
    Buy Aurobindo Pharma; target of Rs 735: ICICI Direct
    moneycontrol.com
    NewsBot
    Aug 8 8:53 PM
    Aurobindo Pharm Standalone June 2019 Net Sales at Rs 3,078.83 crore, up 20.32% Y-o-Y
    moneycontrol.com
    NewsBot
    Aug 8 8:53 PM
    Aurobindo Pharm Consolidated June 2019 Net Sales at Rs 5,444.60 crore, up 28.1% Y-o-Y
    moneycontrol.com
    NewsBot
    Aug 8 7:13 PM
    Aurobindo Pharma climbs 8% after Q1 earnings beat analyst expectations
    moneycontrol.com
    NewsBot
    Aug 8 1:58 PM
    Stocks in the news: Tata Steel, Maruti Suzuki, HCL Tech, Aurobindo, HPCL, Bosch, Siemens
    moneycontrol.com
    NewsBot
    Aug 8 2:43 AM
    Aurobindo Pharma Q1 net rises 40% to Rs 635.8 crore, beats street estimates
    moneycontrol.com
    NewsBot
    Aug 7 1:03 PM
    Stocks in the news: RIL, Indiabulls Housing, IRB Infra, Avenue Supermarts, Jet Airways, Tata Steel
    moneycontrol.com
  • AUROPHARMA - Related Communities

    keyboard_arrow_down
    Help fellow traders de-stress by shar...
    Share and discuss strategies for tax ...
    Want to know more about an upcoming I...
    MCX:MENTHAOIL
    MCX:CPO
    Purpose: Pool and discuss ideas & sug...
    Sector: Index
    Sector: Finance
    Share LINKS, VIDEOS, SITES, BOOKS, JO...
    Share insightful expert analysis and ...
  • AUROPHARMA - More Information

    keyboard_arrow_down

    Aurobindo Pharma Ltd:
    Aurobindo Pharma Limited is propagating its business in researching, developing, manufacturing, and selling of several pharmaceutical products in India. Producing a significant variation in oral and injectable generic formulations, and active pharmaceutical ingredients and manufacturing peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries.
    Along with providing custom research and producing services to biotech and pharmaceutical community the company is reigning over antibiotic, anti-retroviral, cardiovascular, central nervous system, gastroenterological, anti-diabetic, and anti-allergy areas. Besides that, the company is manufacturing proteins, vitamins, minerals, and supplements, sports drinks etc.
    The company is exporting its products to almost 150 countries, including the U.S. and Europe along with serving multinational companies. The company is amongst the largest producers of Ampicillin and Cloxacillin in India. Aurobindo Pharma Limited was established in 1986 as a private limited company and headquartered in Hyderabad, Andhra Pradesh, India.
    About Company Information:
    Aurobindo Pharma was converted to a public limited firm in the year of 1992, after six years from its inception. The company built A CMIC chloride manufacturing unit at Pashamylaram near Hyderabad in the same year. The company started to issue bonus shares in a ratio of 1:1, 2:1 and 7:20 in ’92, ’93 and ’94 respectively. In 1993 the company built up another two plants at Bollaram and Kukatpally near Hyderabad. In 1994, the company increased the capacity at Pondicherry Unit from 204 TPA to 300 TPA along with increasing the installed capacity of its Bollaram unit from 78 TPA to 84 TPA. An amalgamation took place between the company and Chaitanya Organics Pvt. Ltd. in April 1994.
    Glaxo (India), a subsidiary of the U.K. based multinational Glaxo went for an alliance with Aurobindo Pharma in 1997, which increased the number of capsules and bulk drug up to 300 million and 840 tons respectively. In 1998, the company introduced Auronim Suspension in its pediatric segment. In FY 1999-2000, the company added a large section of Cephalosporins (Oral & Sterile) and anti-viral along with macrolides, quinolones, semi-synthetic penicillin, formulating for both the domestic and export market.
    During 2001-02 79% stake in Ranit Pharma Company were acquired by Aurobindo Pharma Ltd. A 50:50 joint venture firm of the company, namely Citadel Aurobindo Biotech Ltd, launched Aztreonam, a Monabactam Beta-lactam antibiotics as a debut in the Indian Pharma Market, TREONAM being the brand name, in 2003. In 2005-06, the company intervened in the markets of USA & Europe, with participation in the PEPFAR program, initiated by the US Govt. In March 2007, the FDA (U.S.) finally approved the company’s Didanosine Oral Suspension (Pediatric Powder) 10 mg/ml.
    Aurobindo Pharma acquired Moore and Carmiooro, the high profile OTC brands from TAD in 2008. AstraZeneca, a leading biopharmaceutical company in the international market, had gone for an agreement with Aurobindo Pharma, for supplying solid dosage and sterile products in 2010. A deal took place between Aurobindo Pharma and National Pharmaceutical Group Corporation, China, for launching the subsidiary Aurobindo (Datong) BioPharma Co Ltd, China (ADBPL).
    In April 2014, Aurobindo Pharma declared the completion of several business operations of Europe’s Actavis plc, an internationally recognized pharmaceutical company, manufacturing and supplying generic, brand and biosimilar products. On November 2016, a subsidiary of Aurobindo Pharma Ltd in France, namely Arrow Generiques SAS, signed an agreement to gain the right, title and interest in its products Calcium and Calcium Vitamin D3 in the French market, including the use of Teva Pharmaceutical Industries OROCAL trademark.
    On January 2017, Aurobindo Pharma declared about setting up a binding agreement by and through its solely owned subsidiary, Agile Pharma B.V., Netherlands, for acquiring Generis Farmaceutica SA, a pharmaceutical company of Portugal, against a lump sum of 135 million Euro totally including net working capital of 21.7 million Euro. On February 2017, four-cell culture derived biosimilar products from T.L. Biopharmaceutical AG were acquired by Aurobindo Pharma as declared by the company.
    How Aurobindo Pharma Ltd, is categorised as a Pharmaceutical and Healthcare Sector, and Pharmaceutical Industry :
    The Pharmaceutical Industry includes companies that derive their business by researching, discovering, developing, manufacturing, and marketing and distributing pharmaceutical medicines and drugs.
    Aurobindo Pharma Ltd is categorized under the Health care sector and Hospitals and Medical services Industry. Healthcare sectors consist of firms involved in the medical space. It is one of the multiple sectors that comprise a range of businesses, including ones that offer medical services directly, or to those that work to develop, create and market medical equipment and medicines. It also includes the other services that provide medical insurance and other related products, and many more.
    The stocks of health care companies mostly have mixed performance. It is due to the inherent challenges to the industry each year, regulatory uncertainties, fiscal policy concerns, and more.
    Aurobindo Pharma Ltd, Competitors and Sector Peers:
    Aarey Drugs & Pharmaceuticals Ltd. AARDRU
    Aarti Drugs Ltd. AARTDR
    Aayush Food & Herbs Ltd. AAYFOO
    Abbott India Ltd. ABBIND
    ABL Bio-Technologies Ltd. ABLBIO
    Addlife Pharma Ltd. ADDPHA
    Bacil Pharma Ltd. BACPHA
    Bafna Pharmaceuticals Ltd. BAFPHA
    Bajaj Healthcare Ltd. BAJHEA
    Brooks Laboratories Ltd. BROLAB
    Cipla Ltd. CIPLTD
    Dishman Pharmaceuticals & Chemicals Ltd.[Merged] DISPHA
    Divi's Laboratories Ltd. DIVIL
    Dr. Reddy's Laboratories Ltd. DR
    Dujohn Laboratories Ltd. DUJLAB
    Earum Pharmaceuticals Ltd.
    Elder Health Care Ltd. ELDHEA
    Elder Pharmaceuticals Ltd. ELDPHA
    Elegant Pharmaceuticals Ltd. ELEPHA
    Gennex Laboratories Ltd. GENLAB
    Genomics Biotech Ltd. GENBIO
    GlaxoSmithKline Pharmaceuticals Ltd. GLAPHA
    Glenmark Pharmaceuticals Ltd. GLEPHL
    IOL Chemicals and Pharmaceuticals Ltd. IOLCHE
    JK Pharmachem Ltd. JKPHAL
    Jubilant Life Sciences Ltd. JUBILO
    Jupiter Bioscience Ltd. JUPIBI
    Lupin Ltd. LUPLTD
    Lyka Labs Ltd. LYKLAB
    Novartis India Ltd. NOVAIN
    Ortin Laboratories Ltd. ORTLAB
    Piramal Enterprises Ltd. NICPIR
    Piramal Phytocare Ltd. PIRLIF
    Ranbaxy Laboratories Ltd. RANLAB
    Sanjivani paranteral Ltd. SANPAR
    Sanofi India Ltd. AVEPHA
    Sarvodaya Labs Ltd. SARLAB
    Sun Pharmaceutical Industries Ltd. SUN28
    TTK Healthcare Ltd. TTKHEA
    Venmax Drugs & Pharmaceuticals Ltd. YENDRU
    Venus Remedies Ltd. VENREM
    Zenith Healthcare Ltd. ZENHEA
    Zenlabs Ethica Ltd. SHRLAK
    Zenotech Laboratories Ltd. ZENLAB
    Zim Laboratories Ltd. ZIMLAB
    Zora Pharma Ltd.[Amalgamated] ZORPHA
    Zota Healthcare Ltd. ZOTHEA
    Zyden Gentec Ltd. ZYDGEN
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.